Loading clinical trials…
Loading clinical trials…
Clinical trials · failure tracking
Oncology studies whose overall status is TERMINATED, WITHDRAWN or SUSPENDED on ClinicalTrials.gov, with the stop reason exactly as the registrant posted it. A category is attached only when an explicit keyword rule matches the text; CancerIndex never infers why a study stopped.
2,226 stopped studies mapped to Malignant Genitourinary System Neoplasm and descendants · 88% state a reason
Over the 2,226 studies matching the cancer, status and year filters (the category filter does not change this chart). Each study is counted once, in the first matching category; greyed bars are studies whose text matched no rule or was empty.
Computedrules ci-stop-reasons-v1 · keyword matching only
A category is assigned when one of its keywords appears in the posted text (case-insensitive, whole words). Rules are tested in this order and the first match wins; every match is kept in the API (reasonMatches).
| NCT | Title | Phase | Status | First posted | Lead sponsor | Why stopped (as posted) | Category |
|---|---|---|---|---|---|---|---|
| NCT00122265 | Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three… | — | terminated | Jul 22, 2005 | AHS Cancer Control Alberta | not stated | Not stated |
| NCT00523471 | Blood Test to Measure DNA Damage in Blood | — | terminated | Aug 31, 2007 | AHS Cancer Control Alberta | not stated | Not stated |
| NCT01514955 | An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in…(IMRT) | Phase 1 | withdrawn | Jan 23, 2012 | AHS Cancer Control Alberta | not stated | Not stated |
| NCT02014831 | Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)(PENILANE) | Phase 2 | withdrawn | Dec 18, 2013 | Centre Leon Berard | Industry decline to supply study drug | Drug supply |
| NCT02470559 | Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients… | Phase 1 | withdrawn | Jun 12, 2015 | Barbara Ann Karmanos Cancer Institute | Study did not accrue any participants, the PI has left the institution. | Enrollment / accrual |
| NCT01916109 | Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in… | Phase 2 | terminated | Aug 5, 2013 | Memorial Sloan Kettering Cancer Center | Lack of accrual | Enrollment / accrual |
| NCT02035124 | Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer… | Phase 2 | withdrawn | Jan 14, 2014 | SCRI Development Innovations, LLC | Study withdrawn due to slow accrual. No patients were enrolled. | Enrollment / accrual |
| NCT02130947 | Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer… | N/A | withdrawn | May 6, 2014 | UNC Lineberger Comprehensive Cancer Center | We were not able to accrue any participants. | Enrollment / accrual |
| NCT01888042 | Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer(POORTOR) | Phase 2 | terminated | Jun 27, 2013 | Gustave Roussy, Cancer Campus, Grand Paris | not stated | Not stated |
| NCT02621684 | Physical Activity Intervention in African American Men After Radical Prostatectomy | N/A | withdrawn | Dec 3, 2015 | Washington University School of Medicine | Not able to enroll any participants due to disinterest | Enrollment / accrual |
| NCT02079155 | Robotic Athermal Nerve-Sparing Radical Prostatectomy | N/A | withdrawn | Mar 5, 2014 | Case Comprehensive Cancer Center | Research Cancelled | Other (stated, no rule matched) |
| NCT01762033 | A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma | Phase 2 | terminated | Jan 7, 2013 | Lpath, Inc. | not stated | Not stated |
| NCT00250757 | Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions | — | terminated | Nov 8, 2005 | New Mexico Cancer Research Alliance | Study was not renewed timely with IRB of record. | Other (stated, no rule matched) |
| NCT00734851 | Multimodality Phase II Study in Prostate Cancer | Phase 2 | terminated | Aug 14, 2008 | Duke University | Dose Limiting Toxicities | Safety / toxicity |
| NCT01624493 | BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients | Phase 1 / Phase 2 | withdrawn | Jun 20, 2012 | Hoosier Cancer Research Network | Phase I was conducted Australia. Phase II not conducted and no US pts enrolled. | Enrollment / accrual |
| NCT01840943 | A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial… | Phase 3 | terminated | Apr 26, 2013 | Xian-Janssen Pharmaceutical Ltd. | the study was terminated due to medication supply issue from current manufacturer | Drug supply |
| NCT01771003 | Remote Ischemia Pre-Conditioning in Patients Undergoing Partial Nephrectomy | N/A | terminated | Jan 18, 2013 | University Health Network, Toronto | not stated | Not stated |
| NCT00480935 | A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma | Phase 2 | terminated | May 31, 2007 | University Health Network, Toronto | poor recruitment | Enrollment / accrual |
| NCT00932672 | Atkins Diet and Prostate Cancer Clinical Trial | Phase 2 | terminated | Jul 3, 2009 | Duke University | slow recruitment, lack of funding and PI transferred | Enrollment / accrual |
| NCT02139774 | Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate… | — | terminated | May 15, 2014 | UNC Lineberger Comprehensive Cancer Center | inadequate accrual | Enrollment / accrual |
| NCT01663285 | Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC) | Phase 2 | terminated | Aug 13, 2012 | University of Michigan Rogel Cancer Center | Low study participant enrollment. | Enrollment / accrual |
| NCT00913913 | Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell… | Phase 2 | terminated | Jun 4, 2009 | Dartmouth-Hitchcock Medical Center | low accrual not allowing site to meeting statistical endpoints | Enrollment / accrual |
| NCT00313612 | Oxaliplatin and Topotecan in Advance Ovarian Cancer | Phase 2 | terminated | Apr 12, 2006 | National Cancer Institute (NCI) | not stated | Not stated |
| NCT00596544 | Sexual Functioning After Primary Treatment of Ovarian Cancer | — | terminated | Jan 17, 2008 | Memorial Sloan Kettering Cancer Center | Lack of accrual | Enrollment / accrual |
| NCT01279785 | A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe… | — | withdrawn | Jan 19, 2011 | Molecular Insight Pharmaceuticals, Inc. | Similar study to be completd once kit for new formulation becomes available. | Other (stated, no rule matched) |
| NCT01977586 | Functional Imaging in the Assessment of mRCC Response to Sunitinib | N/A | withdrawn | Nov 6, 2013 | Imperial College Healthcare NHS Trust | Difficulty in recruiting suitable patients at centre | Enrollment / accrual |
| NCT00974818 | Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of… | Phase 3 | terminated | Sep 10, 2009 | Memorial Sloan Kettering Cancer Center | Lack of accrual | Enrollment / accrual |
| NCT02396368 | A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic…(Radium-223) | Phase 1 | withdrawn | Mar 24, 2015 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase III study results for the drug Tesquinimod were not promising so it was a drug development… | Other (stated, no rule matched) |
| NCT00714948 | Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients… | Phase 2 | terminated | Jul 14, 2008 | Memorial Sloan Kettering Cancer Center | Lack of accrual | Enrollment / accrual |
| NCT00006126 | Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell… | Phase 1 | withdrawn | Mar 8, 2004 | Northwestern University | Unable to accrue subjects. | Enrollment / accrual |
| NCT02024685 | Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial | N/A | terminated | Dec 31, 2013 | Case Comprehensive Cancer Center | Funding unavailable | Funding |
| NCT00479089 | Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer | Phase 2 | terminated | May 25, 2007 | M.D. Anderson Cancer Center | Study halted due to drug sponsor decision to not continue. | Sponsor / business decision |
| NCT00704938 | Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating… | Phase 2 | terminated | Jun 25, 2008 | National Institutes of Health Clinical Center (CC) | Terminated due to withdrawal of support from our collaborator. | Other (stated, no rule matched) |
| NCT00747305 | Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer… | Phase 1 | terminated | Sep 5, 2008 | Harry Drabkin | Study terminated early due to low accrual. | Enrollment / accrual |
| NCT02042885 | A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With… | Phase 1 / Phase 2 | terminated | Jan 23, 2014 | Otsuka Novel Products GmbH | not stated | Not stated |
| NCT00629330 | Dissemination of Prostate Cancer Screening to PCP's in African American Communities | Phase 4 | terminated | Mar 6, 2008 | Columbia University | Principal Investigator left the institution. | Investigator |
| NCT01175967 | Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced… | — | terminated | Aug 5, 2010 | UNC Lineberger Comprehensive Cancer Center | Unable to meet accrual due to changing practice patters | Enrollment / accrual |
| NCT00093678 | Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer | N/A | withdrawn | Oct 8, 2004 | Eastern Cooperative Oncology Group | not stated | Not stated |
| NCT00635726 | Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus… | Phase 2 | terminated | Mar 14, 2008 | Hellenic Oncology Research Group | Due to poor accrual | Enrollment / accrual |
| NCT01342627 | Sorafenib in Elderly Patients With Metastatic Renal Cell Carcinoma(SERCC) | Phase 2 | terminated | Apr 27, 2011 | Centro di Riferimento Oncologico - Aviano | low enrollment rate | Enrollment / accrual |
| NCT01530984 | Ipilimumab and GMCSF Immunotherapy for Prostate Cancer | Phase 2 | withdrawn | Feb 10, 2012 | Lawrence Fong | Unable to execute contract | Other (stated, no rule matched) |
| NCT00585416 | Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer | Phase 2 | terminated | Jan 3, 2008 | University of Wisconsin, Madison | Further evaluation of phase I dosing | Other (stated, no rule matched) |
| NCT00288106 | S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT | — | terminated | Feb 7, 2006 | SWOG Cancer Research Network | Poor accrual resulted in lack of feasibility to evaluate endpoints. | Enrollment / accrual |
| NCT00908739 | Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized… | — | withdrawn | May 27, 2009 | Case Comprehensive Cancer Center | PI left | Investigator |
| NCT00758732 | Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian… | Phase 2 | terminated | Sep 25, 2008 | Hellenic Oncology Research Group | Poor accrual | Enrollment / accrual |
| NCT01745718 | Clinical Study Evaluating Targeted Biopsies and Cytological Imprints in Prostate Cancer | N/A | withdrawn | Dec 10, 2012 | Oslo University Hospital | The study was stopped for technical reasons | Other (stated, no rule matched) |
| NCT02185170 | DEPORRA-CoProst: Assessment of New Fluorescence Imagery Techniques Using Prostate Chips… | N/A | terminated | Jul 9, 2014 | University Hospital, Grenoble | Results of 5 first patients show that chips' cauterization interferes the signal | Other (stated, no rule matched) |
| NCT02480010 | A Study of Pertuzumab in Participants With Prostate Cancer | Phase 2 | terminated | Jun 24, 2015 | Hoffmann-La Roche | The study was terminated at the time of interim analysis since none of the participants showed a… | Efficacy / futility |
| NCT01100242 | Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma | Phase 2 | terminated | Apr 8, 2010 | New Mexico Cancer Research Alliance | Low accrual | Enrollment / accrual |
| NCT00215631 | Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For… | Phase 3 | terminated | Sep 22, 2005 | Erasmus Medical Center | slow recruitment | Enrollment / accrual |
Stop reasons are registrant-reported free text and are displayed verbatim (truncated; hover for the full text). Categories come from explicit keyword rules and are never inferred from the study design, sponsor or outcome; a study that stopped for several reasons is filed under the first rule that matched. A TERMINATED status does not imply a negative result.
Data updated 24 days agoSource updated Feb 26, 2016source: clinicaltrials